Best conditions created for trial of homegrown vaccines
The Standing Board of the National Steering Committee for COVID-19 Prevention and Control has agreed to create the best possible conditions for the trial of homegrown vaccines.
Nano Covax vaccine is researched and developed by the Nanogen Pharmaceutical Biotechnology JSC (Photo: VNA)
Hanoi (VNA) –The Standing Board of the National Steering Committee for COVID-19 Prevention and Control has agreed to create the best possible conditions for the trial ofhomegrown vaccines.
If the trial goes well, in the context ofvaccine scarcity the Ministry of Health will submit to competent agencies forapproval of the use of homegrown vaccines in emergency circumstances.
Several companies haveinvested in plants and are seeking vaccine production technologies both in andoutside the country. At least one large-scale COVID-19 vaccine production plantis scheduled to be put in operation in late 2021 or early 2022.
The Ministry of Health hasurged the Company for Vaccine and Biological Production No.1 (VABIOTECH) to conduct procedures to receive Sputnik V vaccine productiontechnology from Russia in two phases. In the first phase, the company will import materialsfrom Russia for bottling and production is expected to begin in July.
The Ministry of Health willcoordinate with ministries and sectors to submit to the Government a proposalon accessing all vaccine supply sources in the world towards the goal ofachieving herd immunity by the end of 2021, and create mechanisms to facilitateinvestors’ investment in the production of vaccines in the country to serve notonly domestic use but also export./.
Six out of 120 volunteers have been injected with Vietnam’s second homegrown candidate vaccine COVIVAC, as human trials began at the Hanoi Medical University on March 15.
Fifteen more volunteers have been inoculated with Vietnam’s second homegrown candidate vaccine COVIVAC on March 23 as part of its ongoing human trials.
Since the COVID-19 outbreak, the Health Ministry has directed units to study and clinically test made-in-Vietnam vaccines while seeking technological transfer from abroad to proactively fight the pandemic in the country.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
According to the World Health Organisation, more than 25,000 COVID-19 cases have been recorded globally over the past month. Notably, from January 1 to May 10, Thailand reported nearly 54,000 infections and 16 deaths. The rise in cases in Thailand has been linked to the spread of XBB.1.16 subvariant.
Nano Covax vaccine is researched and developed by the Nanogen Pharmaceutical Biotechnology JSC (Photo: VNA) 
